ACR Appropriateness Criteria® Imaging of Invasive Breast Cancer

被引:1
作者
McDonald, Elizabeth S. [1 ]
Scheel, John R. [2 ]
Lewin, Alana A. [3 ]
Weinstein, Susan P. [4 ]
Dodelzon, Katerina [5 ]
Dogan, Basak E. [6 ]
Fitzpatrick, Amy [7 ]
Kuzmiak, Cherie M. [8 ]
Newell, Mary S. [9 ]
Paulis, Lisa V. [10 ]
Pilewskie, Melissa [11 ]
Salkowski, Lonie R. [12 ]
Silva, H. Colleen [13 ]
Sharpe, Richard E., Jr. [14 ]
Specht, Jennifer M. [15 ,16 ]
Ulaner, Gary A. [17 ,18 ,19 ]
Slanetz, Priscilla J. [20 ]
机构
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA USA
[2] Vanderbilt Univ, Med Ctr, 1211 Med Ctr Dr, Nashville, TN 37232 USA
[3] NYU, Grossman Sch Med, New York, NY USA
[4] Univ Penn, Perelman Sch Med, Philadelphia, PA USA
[5] Weill Cornell Newyork Presbyterian, New York, NY USA
[6] Univ Texas Southwestern Med Ctr, Dallas, TX USA
[7] Boston Med Ctr, Boston, MA USA
[8] Univ N Carolina, Chapel Hill, NC USA
[9] Emory Univ Hosp, Atlanta, GA USA
[10] Elizabeth Wende Breast Care, Rochester, NY USA
[11] Univ Michigan, Ann Arbor, MI USA
[12] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
[13] Univ Texas Med Branch, Galveston, TX USA
[14] Mayo Clin, Phoenix, AZ USA
[15] Univ Washington, Seattle, WA USA
[16] Amer Soc Clin Oncol, Seattle, WA USA
[17] Hoag Family Canc Inst, Newport Beach, CA USA
[18] Univ Southern Calif, Los Angeles, CA USA
[19] Commiss Nucl Med & Mol Imaging, Los Angeles, CA USA
[20] Boston Univ, Sch Med, Boston, MA USA
基金
美国国家卫生研究院;
关键词
Appropriateness Criteria; appropriate use criteria; AUC; invasive breast cancer; locoregional disease; metastatic disease; recurrence; staging; surveillance; EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; ENHANCED SPECTRAL MAMMOGRAPHY; NEEDLE-ASPIRATION BIOPSY; NODE-NEGATIVE PATIENTS; AXILLARY LYMPH-NODES; EARLY-STAGE; F-18-FDG PET/CT; TUMOR SIZE; DIGITAL MAMMOGRAPHY; LOBULAR CARCINOMA;
D O I
10.1016/j.jacr.2024.02.021
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
As the proportion of women diagnosed with invasive breast cancer increases, the role of imaging for staging and surveillance purposes should be determined based on evidence-based guidelines. It is important to understand the indications for extent of disease evaluation and staging, as unnecessary imaging can delay care and even result in adverse outcomes. In asymptomatic patients that received treatment for curative intent, there is no role for imaging to screen for distant recurrence. Routine surveillance with an annual 2-D mammogram and/or tomosynthesis is recommended to detect an in-breast recurrence or a new primary breast cancer in women with a history of breast cancer, and MRI is increasingly used as an additional screening tool in this population, especially in women with dense breasts. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
引用
收藏
页码:S168 / S202
页数:35
相关论文
共 213 条
  • [1] Axillary Lymph Nodes Suspicious for Breast Cancer Metastasis: Sampling with US-guided 14-Gauge Core-Needle Biopsy-Clinical Experience in 100 Patients
    Abe, Hiroyuki
    Schmidt, Robert A.
    Kulkarni, Kirti
    Sennett, Charlene A.
    Mueller, Jeffrey S.
    Newstead, Gillian M.
    [J]. RADIOLOGY, 2009, 250 (01) : 41 - 49
  • [2] ABIM/ ASCO Choosing Wisely, Imaging and tumor marker tests for breast cancer. When you need them-and when you don't
  • [3] Evaluation of the Usefulness of Breast CT Imaging in Delineating Tumor Extent and Guiding Surgical Management A Prospective Multi-Institutional Study
    Akashi-Tanaka, Sadako
    Sato, Nobuaki
    Ohsumi, Shozo
    Kimijima, Izo
    Inaji, Hideo
    Teramoto, Seiichi
    Akiyama, Futoshi
    [J]. ANNALS OF SURGERY, 2012, 256 (01) : 157 - 162
  • [4] 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) Imaging in the Staging and Prognosis of Inflammatory Breast Cancer
    Alberini, Jean-Louis
    Lerebours, Florence
    Wartski, Myriam
    Fourme, Emmanuelle
    Le Stanc, Elise
    Gontier, E.
    Madar, O.
    Cherel, P.
    Pecking, A. P.
    [J]. CANCER, 2009, 115 (21) : 5038 - 5047
  • [5] Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer:: A systematic review
    Alvarez, S
    Añorbe, E
    Alcorta, P
    López, F
    Alonso, I
    Cortés, J
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2006, 186 (05) : 1342 - 1348
  • [6] American College of Radiology, ACR Appropriateness Criteria Radiation dose assessment introduction
  • [7] American College of Radiology, ACRSABISARSPR practice parameter for the performance of computed tomography (CT) of the abdomen and computed tomography (CT) of the pelvis
  • [8] Does the Addition of Breast MRI Add Value to the Diagnostic Workup of Invasive Lobular Carcinoma?
    Amin, Amanda L.
    Sack, Stephen
    Larson, Kelsey E.
    Winblad, Onalisa
    Balanoff, Christa R.
    Nazir, Niaman
    Wagner, Jamie L.
    [J]. JOURNAL OF SURGICAL RESEARCH, 2021, 257 : 144 - 152
  • [9] Amin M.B., 2017, AJCC Cancer Staging Manual
  • [10] What is the yield of breast MRI in the assessment of palpable breast findings?
    Amitai, Y.
    Menes, T. S.
    Weinstein, I.
    Filyavich, A.
    Yakobson, I.
    Golan, O.
    [J]. CLINICAL RADIOLOGY, 2017, 72 (11) : 930 - 935